SCHEMBL25589804

SCHEMBL25589804

C=CC(=O)Nc1ccc(-c2c3c4c(ncnc4n2C)NCc2cc(OC)ccc2-3)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 3/20 0.42
▸ FGFR2 P21802 3/20 0.42
▸ FGFR4 P22455 3/20 0.42
▸ FGFR3 P22607 3/20 0.42
▸ TGM2 P21980 1/20 0.41
▸ ERBB2 P04626 2/20 0.38
▸ EGFR P00533 2/20 0.37
▸ JAK3 P52333 3/20 0.37
▸ JAK1 P23458 2/20 0.37
▸ MAP2K7 O14733 1/20 0.37
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ BTK Q06187 3/20 0.36
▸ MET P08581 1/20 0.36
▸ TDP2 O95551 1/20 0.35
▸ PLCG1 P19174 1/20 0.35
▸ GSK3B P49841 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25589205 0.92 FGFR1 (0.41) FGFR1FGFR2FGFR4FGFR3ERBB2
SCHEMBL25589185 0.92 FGFR4 (0.44) FGFR1FGFR2FGFR4FGFR3ERBB2
SCHEMBL25589206 0.91 BTK (0.44) FGFR1FGFR2FGFR4FGFR3TGM2
SCHEMBL25589193 0.91 FGFR4 (0.39) FGFR1FGFR2FGFR4FGFR3ERBB2
SCHEMBL25589190 0.90 FGFR1 (0.42) FGFR1FGFR2FGFR4FGFR3ERBB2
SCHEMBL24992106 0.89 FGFR1 (0.47) FGFR1FGFR2FGFR4FGFR3ERBB2
SCHEMBL25589203 0.89 FGFR1 (0.39) FGFR1FGFR2FGFR4FGFR3ERBB2
SCHEMBL25600094 0.89 FGFR1 (0.45) FGFR1FGFR2FGFR4FGFR3TGM2
SCHEMBL25597080 0.89 FGFR1 (0.42) FGFR1FGFR2FGFR4FGFR3ERBB2
SCHEMBL25589194 0.89 FGFR1 (0.40) FGFR1FGFR2FGFR4FGFR3ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023078413-A1 FGFR2 INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF 微境生物医药科技(上海)有限公司 2023-05-11 — — WO disclosed
Send feedback